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Percutaneous Closure of an Acquired Post-Myocardial
Infarction Ventriculoatrial Gerbode DefectRichard Cheng, MD,* Reza Arsanjani, MD,* Emily Tat, BA,* Justin Cox, MD,* Abhimanyu Uberoi, MD, MS,*
Rebecca Aron, MD,y Saibal Kar, MD*A 58-year-old male patient presented with aninferior ST-segment elevation myocardialinfarction complicated by a ventricular septal
defect (VSD). The VSD was surgically repaired, but
basal extension of necrotic tissue obligated a second
repair 2 weeks later. Subsequently, he again pre-
sented in cardiogenic shock and was found to have
a signiﬁcant residual VSD; he was referred to our
institution for cardiac transplantation.
Transthoracic echocardiogram showed further
basal extension of the VSD (Figure 1A) with left ven-
tricular (LV) to right ventricular shunting. However,
transesophageal echocardiogram instead revealed LV
to right atrial (RA) shunting through an 11-mm Ger-
bode defect with direct extension through the atrio-
ventricular portion of the septum, which was thought
to be from further basal extension of infarct necrosis
(Figure 1B). Percutaneous closure was planned, as
a third sternotomy could preclude future trans-
plantation listing.
Shunt run demonstrated elevated RA pressures,
with a-wave 24 mm Hg and v-wave 28 mm Hg. Shunt
size was estimated at 4.57 l/min (Qp/Qs 1.72). With a
retrograde transfemoral approach and directed by an
internal mammary catheter, a coated guidewire was
advanced through the defect into the RA, where it was
snared and externalized through the internal jugular
vein (Figure 1C). A delivery sheath was advanced overFrom the *Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles,
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cending aorta (Figure 1D), and a 14-mm Amplatzer
atrial septal occluder (St. Jude Medical, St. Paul,
Minnesota) was successfully deployed with minimal
residual shunting (Figures 1E to 1G) and an imme-
diate 4-mm Hg improvement in mean RA and right
ventricular pressures. Shunt size was reduced to
2.18 l/min (Qp/Qs 1.37) with residual shunting through
the device itself, which was expected to improve
with endothelialization. Tricuspid valve leaﬂets were
free from impingement after device deployment as
assessed by transesophageal echocardiogram with no
signiﬁcant regurgitation. The patient was successfully
discharged and was stable at 2-month follow-up.
Acquired Gerbode defects are rare, and percuta-
neous closure has only previously been described
in 3 cases of surgically acquired defects (1–3) but
not after myocardial infarction. In this case, suc-
cessful percutaneous closure allowed for immediate
hemodynamic and clinical stabilization and the
avoidance of a third sternotomy, which may have
excluded the option of cardiac transplantation in
the future.
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FIGURE 1 Echocardiographic and Fluoroscopic-Guided Percutaneous Closure of a Gerbode Defect
(A) Apical 4-chamber view on transthoracic echocardiogram of shunting from the left ventricle (LV) to what appears to be the right ventricle
(RV). (B) Midesophageal 4-chamber view on transesopahgeal echocardiogram instead reveals a Gerbode defect (arrow) to the right atrium
(RA). The left atrium (LA), mitral valve (MV), and tricuspid valve (TV) are also shown. (C) Cranial left anterior oblique view on angiogram shows
a guidewire being snared (arrow). (D) An Amplatzer delivery sheath across the 11-mm defect. (E and F) An Amplatzer 14-mm atrial septal
occluder (arrow) is deployed with minimal residual shunting. (G) 3-dimensional transesophageal echocardiogram shows no residual defect and
a well-situated device (arrow).
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